MIST NASDAQ
Milestone Pharmaceuticals Inc.
1W: +2.7%
1M: -31.4%
3M: -38.7%
YTD: -55.5%
1Y: -52.1%
3Y: -72.7%
5Y: -84.9%
$0.81
-0.01 (-0.74%)
Weekly Expected Move ±8.3%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$2M
+0.0% ▲
Gross Profit
$1M
+0.0% ▲
Operating Income
-$62M
-48.4% ▼
Net Income
-$63M
-51.9% ▼
EPS (Diluted)
$-0.75
-11.9% ▼
EBITDA
-$62M
-64.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15M | $5M | $1M | $0 | $2M |
| YoY Growth | +0.0% | -66.7% | -80.0% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $114K |
| Gross Profit | $15M | $5M | $1M | $0 | $1M |
| Gross Margin | 100.0% | 100.0% | 100.0% | — | 92.6% |
| R&D Expenses | $39M | $40M | $31M | $14M | $18M |
| SG&A Expenses | $19M | $25M | $31M | $28M | $17M |
| Operating Expenses | $58M | $65M | $62M | $42M | $64M |
| Operating Income | -$43M | -$60M | -$61M | -$42M | -$62M |
| Operating Margin | -287.2% | -1192.8% | -6109.8% | — | -4041.7% |
| Interest Expense | $0 | $0 | $3M | -$4M | $4M |
| Income Before Tax | -$43M | -$58M | -$60M | -$42M | -$63M |
| Tax Expense | $0 | $0 | $0 | $0 | -$345K |
| Net Income | -$43M | -$58M | -$60M | -$42M | -$63M |
| Net Margin | -285.7% | -1167.8% | -5968.5% | — | -4078.8% |
| EPS (Diluted) | $-1.02 | $-1.35 | $-1.39 | $-0.67 | $-0.75 |
| EBITDA | -$43M | -$58M | -$57M | -$38M | -$62M |
| Shares Outstanding | 42M | 42M | 43M | 62M | 84M |